Clinical trials recruiting for Breast Cancer Triple Negative
Fewer than 3 recruiting trials found.
2
Recruiting trials
1
US states with sites
2
Countries
50%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cyclophosphamid | 1 |
| Fludarabine | 1 |
| Interleukin-2 | 1 |
| Pembrolizumab | 1 |
| Tumor Infiltrating Lymphocytes (TIL) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 1 |
Top cities
Self-screener
Recruiting trials
- Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
- TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Related conditions
Trials recruiting for Breast Cancer Triple Negative often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Breast Carcinoma 74Breast Cancer Stage III 13Breast Cancer Stage II 14Breast Cancer Metastatic 32Breast Cancer Invasive 18
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Cancer Triple Negative trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.